Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo

Gene Therapy

Volumn 7, Issue 5, 2000, Pages 368-376

  Mavria, G ^a   Jager U ^a   Porter, C D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Endothelial specificity; Hybrid LTR; Transcriptional targeting; Tumour vasculature

Indexed keywords

BETA GALACTOSIDASE; ENDOTHELIN 1 DERIVATIVE; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RETROVIRUS; REVERSE TRANSCRIPTION; TUMOR GROWTH; VASCULARIZATION;

UNIDENTIFIED RETROVIRUS;

EID: 0343340388     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301093     Document Type: Article

References (34)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27-31.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
3. Ingber D et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348: 555-557.
4. Yamaoka M et al. Inhibition of tumour growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 1993; 53: 4262-4267.
5. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 1996; 2: 689-692.
6. O'Reilly MS et al. Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell 1997; 88: 277-285.
7. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407.
8. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumour vasculature in a mouse model. Science 1998; 279: 377-380.
9. Denekamp J. Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer 1982; 45: 136-139.
10. Couture LA, Mullen CA, Morgan RA. Retroviral vector containing chimaeric promoter/enhancer elements exhibit cell-type-specific gene expression. Hum Gene Ther 1994; 5: 667-677.
11. Baum C et al. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7547.
12. Valerio D et al. Retrovirus-mediated gene transfer into embryonal carcinoma and haematopoietic stem cells: expression from a hybrid long terminal repeat. Gene 1989; 84: 419-427.
13. Ferrari G et al. A retrovirus vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther 1995; 6: 733-742.
14. Moore KA et al. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector. Hum Gene Ther 1991; 2: 307-315.
15. Vile RG et al. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology 1995; 214: 307-313.
16. Diaz RM, Eisen T, Hart IR, Vile RG. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma. J Virol 1998; 72: 789-795.
17. Grande A et al. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Blood 1999; 93: 3276-3285.
18. Bull HA et al. Endothelin-1 in human skin: immunolocalisation, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cells. J Invest Dermatol 1991; 97: 618-623.
19. Harats D et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 1995; 95: 1335-1344.
20. Lee M-E, Bloch KD, Clifford JA, Quertermous T. Functional analysis of the endothelin-1 gene promoter. J Biol Chem 1990; 265: 10446-10450.
21. Wilson DB, Dorfman DM, Orkin SH. A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol 1990; 10: 4854-4862.
22. Lee M-E, Temizer DH, Clifford JA, Quertermous T. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 1991; 266: 16188-16192.
23. Lee M-E et al. Regulation of endothelin-1 gene expression by fos and jun. J Biol Chem 1991; 266: 19034-19039.
24. Benz EW, Wydro RM, Nadal-Ginard B, Dino D. Moloney murine sarcoma proviral DNA is a transcriptional unit. Nature 1980; 288: 665-669.
25. Cosset F-L et al. High titre packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
26. Lunardi-Iskandar Y et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375: 64-68.
27. Ades EW et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-690.
28. Inoue A et al. The human preproendothelin-1 gene: complete nucleotide sequence and regulation of expression. J Biol Chem 1989; 264: 14954-14959.
29. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
30. Ferry N et al. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA 1991; 88: 8377-8381.
31. Kay R, McPherson J. Hybrid pUC vectors for addition of new restriction enzyme sites to the ends of DNA fragments. Nucleic Acids Res 1987; 15: 2778.
32. LeDoux JM, Morgan JR, Snow RG, Yarmush ML. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol 1996; 70: 6468-6473.
33. Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
34. Porter CD et al. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol 1998; 72: 4832-4840.